Calidi Biotherapeutics, Inc. (CLDI) › Cash & EquivalentsCalidi Biotherapeutics, Inc. (CLDI) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2021: $1.06M2024: $9.60M$9.60M2021Cash & Equivalents (USD)2024Fiscal YearCash & EquivalentsChange YoY2024$9.60M—2021$1.06M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share